CDXS vs CDNA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 27, 2026
CDXS
CDNA
Investment Advisor Scores
CDNA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CDXS | CDNA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 149.2537 | 94.3396 | CDNA |
| PEG Ratio | 13.5333 | -0.12 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 102.1% | 39.0% | CDXS |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 53.3/100 | 48.0/100 | CDXS |
| Profit Margin | -41.0% | -2.0% | CDNA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CDXS
MarkdownPrice below a falling SMA50 (slope -8.8%), weak momentum, RSI 24
CDNA
MarkupPrice above SMA50, rising 50-day trend (23.4% over 20 days), RSI 77
Fundamentals Snapshot
| Metric | CDXS | CDNA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -3.8 | 38.5 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 1.0% | 0.4% |
| Gross Margin | 0.2% | 0.7% |
| Operating Margin | -0.5% | 0.0% |
| EPS | -0.35 | -0.17 |
| Dividend Yield | — | — |